SharpMind Mood

SharpMind Mood

Solaray4.6 (88 ratings)
Format:Capsule Quantity: 30 VegCap(s) · 30 servings
Goals
$26.34 $0.87 per serving

Product analysis

71 out of 100

SharpMind Mood is intended for mood support, but evidence for prescription lithium does not establish the same effect from this supplement.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality87

Lithium orotate is clearly identified and has a favorable compound comparison. The plant mixtures lack enough detail to judge their quality confidently.

Ingredient Transparency73

Declared amounts and mostly named preparations help with comparisons. The holy-basil and reishi mixtures lack complete breakdowns.

Value For Money40

The lithium-linked serving comparison indicates limited value. Value for the holy-basil and reishi mixtures remains uncertain.

Customer Satisfaction68

Customer ratings indicate high satisfaction. The small review base leaves uncertainty about whether that experience is typical.

Product Focus78

Mood support is the intended purpose, but prescription-lithium findings do not establish a benefit from this serving. The holy-basil mixture also does not identify a preparation with demonstrated mood effects.

Format
Capsule
Container
30 VegCap(s)
Per serving
$0.87
Customer rating
4.6 · 88 ratings
Report analysis

Goals

Mood Support
Impact
High effect
B Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic

Lithium is the ingredient linked to mood in the saved findings, but evidence for prescription lithium cannot be transferred to this 5 mg lithium-orotate serving. Holy basil is described as a stress adaptogen without direct mood-outcome evidence, and its mixed extract declaration does not establish a studied preparation. The supplied facts therefore do not support a demonstrated mood improvement from these ingredients at this serving.

How this product is rated for Mood Support

Ingredient fit79

Lithium receives the saved contribution, but its supplement-level mood benefit remains unestablished. Holy basil lacks direct mood-outcome support.
Goal fit
Lithium supplies the saved contribution within a mixed formula; the other assessed botanical has no direct mood-outcome support.
Dose adequacy
The declared 5 mg lithium amount meets the saved reference, but that reference does not establish an effective supplement dose for mood.

Pathways56

The saved findings focus on neuroinflammation and neuroplasticity, without establishing that this supplement produces a meaningful mood effect through that route.
Depth
The saved findings concentrate on neuroinflammation and neuroplasticity; they do not demonstrate these effects from lithium orotate at this supplement exposure.
Breadth
Only the neuroinflammation and neuroplasticity route is represented; stress regulation, calming and monoamine signalling receive no contribution.

Evidence82

The supplied context distinguishes prescription lithium evidence from low-dose supplements; it does not establish mood benefit from this lithium-orotate serving.
Evidence strength
Lithium leads the saved evidence comparison, but prescription lithium findings cannot establish mood benefit from this low-dose lithium-orotate supplement.
Studied preparation
The saved preparation finding is favorable, although supplied context does not establish lithium orotate as a demonstrated mood-effective preparation at this exposure.

Formulation logic100

No configured conflict or missing partner was found, and lithium meets the saved amount criterion. Those findings do not establish clinical mood efficacy.
Partner coverage
The saved contribution has no unmet required partner; this does not demonstrate benefit from the combination.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
Lithium meets the saved amount criterion, which is not a clinically established minimum effective mood dose.
Study evidence
Lithium Supportive 197 studies

Ingredients

IngredientAmount per servingScore
Zembrin extract
25 mg
Holy Basil Extract (Ocimum tenuiflorum Aerial Parts Extract, Ocimum tenuiflorum Flower Extract, Ocimum tenuiflorum Leaf Extract, Ocimum tenuiflorum Seed Extract)
200 mg
Reishi Mushroom (Ganoderma lucidum, Oats)
200 mg
Lithium (Lithium Orotate)
5 mg 88
Gluten Free Adults 18–50 Vegan Dairy Free Women Children 4+ Vegetarian
Report overview
A+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyD- Value
A serving provides 5 mg of lithium from lithium orotate. The whole-product serving costs about $0.88.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

Lithium is supplied as lithium orotate.
Lithium Compound Optimization
Lithium is supplied as lithium orotate.

Dose, Safety & Label Transparency100

The label specifies 5 mg of elemental lithium per serving.
Elemental Disclosure Precision
The label specifies 5 mg of elemental lithium per serving.
Dosage Appropriateness
A serving provides 5 mg of elemental lithium.

Value40

A whole-product serving costs about $0.88.
Cost Per Serving Efficiency
A whole-product serving costs about $0.88.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
    Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M · Bipolar disorders · 2019
    Guideline / consensusMood Support forLithium
  2. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
    Young RC; Mulsant BH; Sajatovic M; Gildengers AG; Gyulai L; Al Jurdi RK; Beyer J; Evans J; Banerjee S; Greenberg R; Marino P; Kunik ME; Chen P; Barrett M; Schulberg HC; Bruce ML; Reynolds CF; Alexopoulos GS; GERI-BD Study Group · The American journal of psychiatry · 2017
    Randomized trial224 participantsMood Support forLithium
  3. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J; Lamictal 606 Study Group · Archives of general psychiatry · 2003
    Randomized trial175 participantsMood Support forLithium
  4. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N · Molecular psychiatry · 2022
    Meta-analysis9,821 participants41 studies pooledMood Support forLithium
  5. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R · The Journal of clinical psychiatry · 2004
    Meta-analysis638 participants2 studies pooledMood Support forLithium